EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19

Taravat Talebi iD, Tannaz Masoumi iD, Katayoun Heshmatzad iD, Mahshid Hesami iD, Majid Maleki iD, Samira Kalayinia iD

Genetics Research · 2023

DOI: 10.1155/2023/2593199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics Research, 2023. Verfasst von Taravat Talebi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iran University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Health and economies are both affected by the coronavirus disease-19 (COVID-19) global pandemic. Angiotensin-converting enzyme 2 (ACE2) is a polymorphic enzyme that is a part of the renin-angiotensin system, and it plays a crucial role in viral entry. Previous investigations and studies revealed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ACE2 have a considerable association. Recently, ACE2 variants have been described in human populations in association with cardiovascular and pulmonary conditions. In this study, genetic susceptibility to COVID-19 in different populations was investigated. Methods and Results. We evaluated the identified variants based on the predictive performance of 5 deleteriousness-scoring methods and the 2015 American College of Medical Genetics and Genomics (ACMG) guidelines. The results indicated 299 variants within the ACE2 gene. The variants were analyzed by different in-silico analysis tools to assess their functional effects. Ultimately, 5 more deleterious variants were found in the ACE2 gene.

Conclusions

Collecting more information about the variations in binding affinity between SARS-CoV-2 and host-cell receptors due to ACE2 variants leads to progress in treatment strategies for COVID-19. The evidence accumulated in this study showed that ACE2 variants in different populations may be associated with the genetic susceptibility, symptoms, and outcome of SARS-CoV-2 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansAngiotensin-Converting Enzyme 2AngiotensinsGenetic Predisposition to DiseaseGenetic VariationSARS-CoV-2

Substanzen

Angiotensin-Converting Enzyme 2AngiotensinsACE2 protein, human

Autor:innen und Institutionen

  • Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Cardiogenetic Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Taravat Talebi, Tannaz Masoumi, Katayoun Heshmatzad, Mahshid Hesami, Majid Maleki, Samira Kalayinia

Förderung

  • Iran University of Medical Sciences

Zitieren

APA

Talebi, T., Masoumi, T., Heshmatzad, K., Hesami, M., Maleki, M., & Kalayinia, S. (2023). Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19. Genetics Research. https://doi.org/10.1155/2023/2593199

Vancouver

Talebi T, Masoumi T, Heshmatzad K, Hesami M, Maleki M, Kalayinia S. Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19. Genetics Research. 2023. doi:10.1155/2023/2593199

BibTeX
@article{Talebi2023,
  author = {Talebi, Taravat and Masoumi, Tannaz and Heshmatzad, Katayoun and Hesami, Mahshid and Maleki, Majid and Kalayinia, Samira},
  title = {Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19},
  journal = {Genetics Research},
  year = {2023},
  doi = {10.1155/2023/2593199}
}
Kostenlos starten →